These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 34818472)

  • 61. Therapeutic anticoagulation for venous thromboembolism after recent brain surgery: Evaluating the risk of intracranial hemorrhage.
    de Melo Junior JO; Lodi Campos Melo MA; da Silva Lavradas LA; Ferreira Lopes PG; Luiz Ornelas II; de Barros PL; da Mata Pereira PJ; Niemeyer Filho P
    Clin Neurol Neurosurg; 2020 Oct; 197():106202. PubMed ID: 32916398
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Cerebral Venous Sinus Thrombosis as a Rare Complication of Systemic Lupus Erythematosus: Subgroup Analysis of the VENOST Study.
    Duman T; Demirci S; Uluduz D; Kozak HH; Demir S; Mısırlı CH; Küçükoğlu H; Çınar N; Domaç FM; Öztürk Ş; ; Sungur MA; Yayla V; Karahan AY; Afşar N; Göksu EÖ; Aytaç E; Yeşilot N; İnce B; Yalın OÖ; Oruç S; Senol MG; Yılmaz A; Gökçe M; Küsbeci ÖY; Uzuner G; Batur Çağlayan HZ; Açıkgöz M; Kurucu H; Ozdag F; Ekmekci H; Çabalar M; Yurekli VA; Güneş T; Genç H; Utku U; Şahin Ş; Tokuc FEU; Uzuner N; Bektaş H; Kablan Y; Göksel BK; Milanlıoğlu A; Örken DN; Aluclu U; Midi İ; Çolakoğlu S; Tüfekçi A; Bakar M; Nazlıel B; Taşçılar N; Göksan B
    J Stroke Cerebrovasc Dis; 2019 Dec; 28(12):104372. PubMed ID: 31562041
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Duration of anticoagulation after cerebral venous sinus thrombosis.
    Caprio F; Bernstein RA
    Neurocrit Care; 2012 Apr; 16(2):335-42. PubMed ID: 22189571
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant Therapy.
    Palareti G; Leali N; Coccheri S; Poggi M; Manotti C; D'Angelo A; Pengo V; Erba N; Moia M; Ciavarella N; Devoto G; Berrettini M; Musolesi S
    Lancet; 1996 Aug; 348(9025):423-8. PubMed ID: 8709780
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Prescription Patterns of Non-Vitamin K Oral Anticoagulants Across Indications and Factors Associated with Their Increased Prescribing in Atrial Fibrillation Between 2012-2015: A Study from the Norwegian Prescription Database.
    Urbaniak AM; Strøm BO; Krontveit R; Svanqvist KH
    Drugs Aging; 2017 Aug; 34(8):635-645. PubMed ID: 28710707
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Cerebral venous sinus thrombosis associated with cerebral hemorrhage: is anticoagulant treatment safe?
    Fuentes B; Martínez-Sánchez P; Raya PG; Abenza MJ; Tejedor ED
    Neurologist; 2011 Jul; 17(4):208-10. PubMed ID: 21712666
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Association Between Use of Non-Vitamin K Oral Anticoagulants With and Without Concurrent Medications and Risk of Major Bleeding in Nonvalvular Atrial Fibrillation.
    Chang SH; Chou IJ; Yeh YH; Chiou MJ; Wen MS; Kuo CT; See LC; Kuo CF
    JAMA; 2017 Oct; 318(13):1250-1259. PubMed ID: 28973247
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Safety and efficacy of direct oral anticoagulants for venous thromboembolism and stroke prophylaxis in patients with hematologic malignancies.
    Kim S; Namba J; Goodman AM; Nguyen T; Saunders IM
    J Oncol Pharm Pract; 2020 Mar; 26(2):351-360. PubMed ID: 31142232
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Comparative Stroke, Bleeding, and Mortality Risks in Older Medicare Patients Treated with Oral Anticoagulants for Nonvalvular Atrial Fibrillation.
    Graham DJ; Baro E; Zhang R; Liao J; Wernecke M; Reichman ME; Hu M; Illoh O; Wei Y; Goulding MR; Chillarige Y; Southworth MR; MaCurdy TE; Kelman JA
    Am J Med; 2019 May; 132(5):596-604.e11. PubMed ID: 30639551
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Comparing the Effectiveness and Safety of Nonvitamin K Antagonist Oral Anticoagulants and Warfarin in Elderly Asian Patients With Atrial Fibrillation: A Nationwide Cohort Study.
    Chao TF; Chiang CE; Liao JN; Chen TJ; Lip GYH; Chen SA
    Chest; 2020 May; 157(5):1266-1277. PubMed ID: 31809694
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Clinical course of cerebral sinus venous thrombosis. Data from a monocentric cohort study over 15 years].
    Geisbüsch C; Lichy C; Richter D; Herweh C; Hacke W; Nagel S
    Nervenarzt; 2014 Feb; 85(2):211-20. PubMed ID: 24469382
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Cerebral Venous Thrombosis at High Altitude: Analysis of 28 Cases.
    Hassan WU; Syed MJ; Alamgir W; Awan S; Bell SM; Majid A; Wasay M
    Cerebrovasc Dis; 2019; 48(3-6):184-192. PubMed ID: 31775151
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Novel factor xa inhibitor for the treatment of cerebral venous and sinus thrombosis: first experience in 7 patients.
    Geisbüsch C; Richter D; Herweh C; Ringleb PA; Nagel S
    Stroke; 2014 Aug; 45(8):2469-71. PubMed ID: 25070963
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Clinical Characteristics of Cerebral Venous Sinus Thrombosis in Patients with Systemic Lupus Erythematosus: A Single-Centre Experience in China.
    Wang L; Chen H; Zhang Y; Liu W; Zheng W; Zhang X; Zhang F
    J Immunol Res; 2015; 2015():540738. PubMed ID: 26090493
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A Review of the Efficacy and Safety Profiles of the Novel Oral Anticoagulants in the Treatment and Prevention of Venous Thromboembolism.
    Coulis AA; Mackey WC
    Clin Ther; 2018 Dec; 40(12):2140-2167. PubMed ID: 30409498
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Safety of Direct Oral Anticoagulants in Central Nervous System Malignancies.
    Swartz AW; Drappatz J
    Oncologist; 2021 May; 26(5):427-432. PubMed ID: 33523555
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Cerebral Venous Sinus Thrombosis Presenting Feature of Systemic Lupus Erythematosus.
    Singh RK; Bhoi SK; Kalita J; Misra UK
    J Stroke Cerebrovasc Dis; 2017 Mar; 26(3):518-522. PubMed ID: 28065614
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Nonabducent Cranial Neuropathies in Cerebral Venous Sinus Thrombosis: A Case Report and Literature Review.
    Nagaraja N; Sabu S
    Neurologist; 2021 May; 26(3):90-97. PubMed ID: 33942790
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Unanswered questions and research priorities to optimise stroke prevention in atrial fibrillation with the new oral anticoagulants.
    Hankey GJ
    Thromb Haemost; 2014 May; 111(5):808-16. PubMed ID: 24285341
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Pharmacological management of cerebral venous sinus thrombosis with full-dose IV heparin infusion and its clinical outcomes.
    Fernandez A; Nair V; Mckeone A; Ho J
    Am J Emerg Med; 2017 Aug; 35(8):1208.e1-1208.e3. PubMed ID: 28434771
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.